Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
I
461030
vs
K
KOSPI 200
Over the past 12 months, IMBDX Inc has underperformed KOSPI 200, delivering a return of -73% compared to KOSPI 200's +119% growth.
Stocks Performance
461030 vs KOSPI 200
Performance Gap
461030 vs KOSPI 200
Performance By Year
461030 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
IMBDX Inc
Glance View
IMBDX Inc. develops molecular diagnostic tests, with a focus on cancer detection and disease screening. Its business centers on lab-based test kits and related analysis services that help hospitals, clinics, and diagnostic labs identify disease from patient samples such as blood or tissue. The company makes money by selling its diagnostic products to medical institutions and, in some cases, by providing testing services through partner laboratories. That puts IMBDX in a key spot in the healthcare value chain: it turns biological samples into clinically useful results, which is different from drug companies that treat disease or device makers that provide hospital equipment.